Shabbir T. Anik's most recent trade in Sutro Biopharma Inc was a trade of 40,000 Restricted Stock Unit (RSU) done . Disclosure was reported to the exchange on March 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 40,000 | 40,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 8,750 | 47,049 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 8,750 | 17,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 7,875 | 38,299 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 7,875 | 23,625 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.79 per share. | 03 Mar 2023 | 6,222 | 40,827 (0%) | 0% | 5.8 | 36,025 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 4,500 | 32,259 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 4,500 | 4,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 27 Jan 2023 | 1,835 | 30,424 (0%) | 0% | 7.5 | 13,763 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 42,000 | 42,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 31,500 | 31,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 8,750 | 30,959 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 8,750 | 26,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. | 04 Mar 2022 | 3,200 | 27,759 (0%) | 0% | 8.2 | 26,144 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 4,500 | 24,053 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 4,500 | 9,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.39 per share. | 29 Jan 2022 | 1,844 | 22,209 (0%) | 0% | 10.4 | 19,159 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 8,609 | 22,529 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 8,609 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.23 per share. | 24 Sep 2021 | 2,976 | 19,553 (0%) | 0% | 19.2 | 57,228 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 35,000 | 35,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 4,500 | 15,765 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 4,500 | 13,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.15 per share. | 29 Jan 2021 | 1,845 | 13,920 (0%) | 0% | 22.2 | 40,867 | Common Stock |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 8,609 | 14,241 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 8,609 | 8,609 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Shabbir T. Anik | Chief Technical Ops. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.30 per share. | 25 Sep 2020 | 2,976 | 11,265 (0%) | 0% | 10.3 | 30,653 | Common Stock |